Cargando…

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis

PURPOSE: Hangeshashinto (TJ-14, a Kampo medicine), which reduces the level of prostaglandin E2 and affects the cyclooxygenase activity, alleviates chemotherapy-induced oral mucositis (COM). We conducted a double-blind, placebo-controlled, randomized comparative trial to investigate whether TJ-14 pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuda, Chu, Munemoto, Yoshinori, Mishima, Hideyuki, Nagata, Naoki, Oshiro, Mitsuru, Kataoka, Masato, Sakamoto, Junichi, Aoyama, Toru, Morita, Satoshi, Kono, Toru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485889/ https://www.ncbi.nlm.nih.gov/pubmed/25983022 http://dx.doi.org/10.1007/s00280-015-2767-y

Ejemplares similares

The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)
por: Nishikawa, Kazuhiro, et al.
Publicado: (2018)

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
por: Aoyama, Toru, et al.
Publicado: (2014)

Topical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis
por: Kono, Toru, et al.
Publicado: (2010)

Effects of Topical Hangeshashinto (TJ-14) on Chemotherapy-Induced Oral Mucositis
por: Ozawa, Natsuo, et al.
Publicado: (2020)

Multicenter phase II study of infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first-line treatment in patients with metastatic colorectal cancer (CELINE trial)
por: Kotake, Masanori, et al.
Publicado: (2017)

Effects of Hangeshashinto on Growth of Oral Microorganisms
por: Fukamachi, Haruka, et al.
Publicado: (2015)

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
por: Kono, Toru, et al.
Publicado: (2013)

The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis
por: Miyano, Kanako, et al.
Publicado: (2020)

Author Correction: The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis
por: Miyano, Kanako, et al.
Publicado: (2020)

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.
por: O'Byrne, K. J., et al.
Publicado: (1998)

Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)
por: Ishibashi, Keiichiro, et al.
Publicado: (2021)

The value of fluorinated pyrimidines in advanced malignancy.
por: Fennelly, J. J., et al.
Publicado: (1968)

Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine
por: Gmeiner, William H.
Publicado: (2020)

Randomized phase II study of TJ-54 (Yokukansan) for postoperative delirium in gastrointestinal and lung malignancy patients
por: Sugano, Nobuhiro, et al.
Publicado: (2017)

Hangeshashinto for preventing oral mucositis in patients receiving cancer treatment: protocol for a systematic review and meta-analysis
por: Wang, Yu-Ting, et al.
Publicado: (2021)

Analysis of the antioxidative function of the radioprotective Japanese traditional (Kampo) medicine, hangeshashinto, in an aqueous phase
por: Matsumoto, Chinami, et al.
Publicado: (2015)

Hangeshashinto for prevention of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized phase II study
por: Yoshimatsu, Masako, et al.
Publicado: (2023)

Acute Cardiogenic Shock Induced by Infusional 5-Fluorouracil
por: Sulpher, Jeffrey, et al.
Publicado: (2014)

Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux
por: Morita, Terumi, et al.
Publicado: (2012)

Enhanced anastomotic healing by Daikenchuto (TJ-100) in rats
por: Wada, Toshiaki, et al.
Publicado: (2018)

Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
por: Gonzalez, M A, et al.
Publicado: (2003)

Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.
por: Gabra, H., et al.
Publicado: (1996)

Successful infusional 5-fluorouracil administration in a patient with vasospastic angina
por: Tai, Shannon, et al.
Publicado: (2022)

Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study)
por: Nakamura, Masato, et al.
Publicado: (2016)

Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2016)

Acceleration of small bowel motility after oral administration of dai-kenchu-to (TJ-100) assessed by cine magnetic resonance imaging
por: Inoue, Akitoshi, et al.
Publicado: (2018)

Uso de infusiones en el control de plagas en huertos familiares
por: Miranda Amador, Salvador
Publicado: (1986)

High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.
por: Yeh, K. H., et al.
Publicado: (1997)

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
por: Lynch, Ryan C., et al.
Publicado: (2022)

Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen.
por: Bonnefoi, H., et al.
Publicado: (1996)

No Significant Effect of Daikenchuto (TJ-100) on Peritoneal IL-9 and IFN-γ Levels After Pancreaticoduodenectomy
por: Maeda, Hiromichi, et al.
Publicado: (2020)

Effect of Traditional Japanese Medicine, Daikenchuto (TJ-100) in Patients With Chronic Constipation
por: Horiuchi, Akira, et al.
Publicado: (2010)

Difference in the Inhibitory Effect of Temozolomide on TJ905 Glioma Cells and Stem Cells
por: Jin, Feng, et al.
Publicado: (2017)

The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study.
por: Singer, J. M., et al.
Publicado: (1998)

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma
por: Martin-Liberal, Juan, et al.
Publicado: (2013)

Systematic Studies on the Effect of Fluorine Atoms in Fluorinated Tolanes on Their Photophysical Properties
por: Morita, Masato, et al.
Publicado: (2021)

The Japanese Herbal Medicine Hangeshashinto Induces Oral Keratinocyte Migration by Mediating the Expression of CXCL12 Through the Activation of Extracellular Signal-Regulated Kinase
por: Miyano, Kanako, et al.
Publicado: (2022)

Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer
por: Munemoto, Yoshinori, et al.
Publicado: (2015)

Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy.
por: Mainwaring, P. N., et al.
Publicado: (1997)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6ok4mnj1eqegp1l6lkeglup5bh